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1F11 monobody binding to Src in lysates from cells +/-the Src activator Ciglitazone. GN4 cells were either untreated, treated with vehicle DMSO, vehicle plus pervanadate pretreatment (P), 50 µM Ciglitazone (Cig), or Ciglitazone with pervanadate pretreatment. Immunoblot (full blot shown here) was used to assay pulldown of Src by beads alone (B), the 1F11 monobody (1F11), control nonbinding monobody (wt FN3), GFP-1F11 with sub-optimal linker (G1F) or GFP-FN3 sub-optimal linker (GFN). Dye labeled GFP-1F11 with short, sub-optimal linker does not respond to cSrc SH3. Emission spectra showing no change in the dye emission for GFP-1F11-mero87 (5 µM)(short linker) after addition of c-Src SH3 (25 µM). 1F11 mutant with cysteine insertion at residue 53 was used for fusion and dye labeling;  Ex =596 nm. GKLPVPWPTL VTTLTWGVQC FARYPDHMKQ HDFFKSAMPE GYVQERTIFF KDDGNYKTRA  EVKFEGDTLV NRIELKGIDF KEDGNILGHK LEYNAISDNV YITADKQKNG IKANFKIRHN  IEDGSVQLAD HYQQNTPIGD GPVLLPDNHY LSTQSKLSKD PNEKRDHMVL LEFVTAAGIT  LGMDELYKGS GSGSTSGSGK PGSGEGSTKG SVSDVPRKLE VVAATPTSLL ISWDAPGISQ  GYYRITYGET GGNSPVQEFT VPGSKSTATI SGLKPGVDYT ITVYAYSRPL In red is the alanine residue in 1F11 that was mutated to cysteine for dye labeling in the final merobody Src family sensor (see main text). In purple is the proline residue (P80) that was mutated to alanine in non-binding control. In orange are other residues screened for dye placement and optimization. 
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Cell culture.
GN4 rat liver epithelial cells were grown in Richter's minimal essential medium supplemented with 10% heat-inactivated fetal bovine serum and penicillin/streptomycin/amphotericin B as described previously 2 . NIH 3T3 fibroblasts (MEFs) were cultured in 5% CO2 at 37°C in Dulbecco's modified Eagle's medium (DMEM, Mediatech) supplemented with 10 % fetal calf serum, 1 % L-Glutamine, and 1% penicillin streptomycin. PTK1 cells (ATCC CCL-35) were cultured in DMEM/F12 media (Gibco) supplemented with 8 % fetal calf serum, 1 % L-Glutamine, and 1% penicillin/streptomycin. MEFs and PTK1 cells were imaged in Ham's F-12K medium without phenol red (SAFC Biosciences) with 2% fetal bovine serum, 15mM HEPES, 1 % L-Glutamine, and 1% penicillin streptomycin.
Biosensor design and construct generation.
The biosensor construct was generated by overlapping PCR followed by restriction digestion and ligation into a modified pQE vector. The final biosensor construct has a 5' hexa-his tag, followed by NTs coding for mCerulean 3 , a linker sequence and 1F11. See supplementary Figure 8 for the design and amino acid sequence of the biosensor. Various cysteine mutants as well as single proline point mutants were generated using the Quikchange (Stratagene) point mutagenesis kit starting with the mCerulean-linker-1F11 clone. Residue Alanine 24 of 1F11 was mutated to cysteine in the final biosensor construct. Nonbinding versions of SFK merobody sensors were created by mutating proline 80 of 1F11 into alanine also using the Quikchange kit.
Protein expression and purification.
FN3 monobodies, including the binder 1F11 and wt FN3 (non-binding control) were expressed in E.coli BL21 (DE3) as described earlier 4 . The monobodies having a hexa-His tag were purified using Ni-affinity columns (His GraviTrap™) purchased from Amersham/GE healthcare as per manufacturer's instructions. A step gradient of imidazole was used in the elution of the proteins from the His GraviTrap™ columns to increase purity.
1F11-mCerulean fusion proteins were expressed in E.coli BL21 (DE3) as reported earlier 4 . Briefly, 1L cultures were induced with 1mM IPTG at RT for 14-16 hours before harvesting the bacteria. The biosensor fusion proteins with hexa-His tags were purified using Ni-affinity columns as described above. The proteins were examined for purity using SDS-PAGE.
Pulldown and in-vitro kinase experiments.
Cell Lysate Preparation: Prior to experiments, GN4 cells at 70-80% confluency were serum-starved overnight in Richter's minimum essential medium containing 0.1% fetal bovine serum. Following treatment as indicated, media was aspirated, and the cells were rinsed twice with ice-cold PBS. The cells were then scraped into ice-cold RIPA buffer (150 mM NaCl, 9.1 mM Na 2 HPO 4 , 1.7 mM NaH 2 PO4, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS, pH 7.4) with freshly added 200 M Na 3 VO 4 , 250 M phenylmethylsulfonyl fluoride, 5 g/ml leupeptin, and 10 nm microcysteine. The cell lysates were clarified by centrifugation at 14,000 rpm for 10 min at 4 °C. Protein concentration of the supernatant was determined using the Coomassie protein assay reagent (Pierce).
Immunoblotting: In a typical experiment, 10 g of cell lysate was resuspended in SDS-PAGE sample buffer (0.5 M Tris, pH 6.8, 4% SDS, 20% glycerol, 10% -mercaptoethanol, 0.1% bromphenol blue) and heated at 95 °C for 5 min to denature proteins. The lysates were then resolved by SDS-PAGE on NuPAGE precast 10% Bis-Tris or NOVEX Tris-glycine gels (Invitrogen) and transferred to polyvinylidene fluoride (Immobilon-P; Millipore). The immunoblots were incubated with the appropriate primary antibody overnight at 4 °C, washed three times with TBST, and probed with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature. Immunoblots were then developed with ECL (Amersham Biosciences) according to the manufacturer's instructions and visualized by autoradiography (Kodak X-Omat Blue film). For immunoblotting for total Src, antibodies B-12 and N-16 (Santa Cruz) were used.
Cell treatment: GN4 cells grown as described above were either left untreated before lysis, treated with vehicle (DMSO), or treated with a DMSO solution of Ciglitazone (Biomol), (±)-5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione, for either 10 or 30 minutes such that the final concentration of Ciglitazone was 50 M. In order to inhibit phosphatases in a global manner, GN4 cells were pretreated with 50 M pervanadate for 5 minutes.
Pull down assay: 200 g of lysates (in RIPA buffer, no SDS) from GN4 cells, treated as described above, were incubated with 100 g of either 1F11 or wt FN3 preabsorbed on 15 L Ni sepharose (Qiagen) beads overnight with gentle agitation, in the presence of 20 mM Imidazole. The beads were washed once with RIPA (no SDS), thrice with ice cold PB and then resuspended in 20 L Laemmeli buffer, boiled for 5 mintes, and subjected to SDS-PAGE, followed by analysis by western blots to look at total Src pulled-down by either the binder or control proteins.
In Vitro Src Kinase Assay: Src kinase activity in Src protein pulled down by either the binder (1F11) or wt FN3 from stimulated or unstimulated GN4 cells was measured using a commercial Src assay kit (Upstate Biotechnology, Inc.) according to the manufacturer's instructions. Briefly, Src was subjected to FN3 pulldown as described above from 200 g of cell lysate by overnight incubation with either the binder or control. Src activity present in FN3-bead complexes was assessed by measuring the transfer of the -phosphate of [-32 P]ATP to a specific Src substrate peptide for 10 min at 30 °C. Phosphorylated substrate was then separated from residual [-32 P]ATP using P-81 phosphocellulose paper (Whatman) and quantified with a scintillation counter. The data reported here is an average of three independent experiments.
Dye labeling.
DMSO solutions of cysteine-reactive merocyanine dyes (10-20 mM) were added to 1F11-mCerulean fusion proteins (200-300 µM) in 50 mM HEPES, 100 mM NaCl buffer pH 7.4 such that the dye was present in 5-10 fold molar excess and the DMSO in the reaction mixture was less than 10%. After reaction for 4-5 hours, excess dye was separated from labeled protein using size exclusion G-25 (GE healthcare) columns. During G-25 size exclusion, a clear separation was seen between the labeled protein band and the relatively immobile free dye. Labeled proteins were subjected to SDS-PAGE electrophoresis and a single fluorescent band was observed (controls in which labeled monobody and dye were mixed showed that free dye could be observed as a separate band of lower molecular weight). Coomassie labeling was also used to verify homogeneity of the biosensor preparations. Labeling efficiency was calculated by measuring the dye and protein concentrations of the labeled conjugate. Dye concentration was estimated using dye absorbance at absorption maxima after dissolving the conjugate in DMSO. Extinction coefficients have been reported elsewhere 5, 6 . Protein concentration was estimated by using absorbance due to the mCerulean FP (molar extinction coefficient 43,000). Labeling efficiency was estimated to be in the range of 0.9-1.2 dye/protein molar ratio, for the various preparations tested. Binding to SH3 was compared for individual batches and similar results were obtained. Also, independent batches gave consistent results in live cell imaging experiments.
Binding assays.
The SH3 domain of c-Src was expressed, purified and analyzed as described earlier 4 . In vitro response of the biosensor was tested by recording fluorescence spectra of biosensor samples incubated with increasing concentrations of Src SH3 domain in PBS pH 7.4 at room temperature, using a SPEX fluorolog 3 spectrophotometer. Ratiometric response was measured by recording dye fluorescence ( ex 590 nm and  em 620 nm) as well as the mCerulean fluorescence ( ex 433 and  ex 477 nm). For estimation of binding constants, the average of three separate titrations was used. Each individual titration experiment consisted of samples measured in duplicate.
Microscopy.
For imaging experiments MEFs and PTK1 cells were plated onto coverslips coated with 5g/mL Fibronectin (Sigma) overnight. Culture media was exchanged for imaging media for one hour prior to microinjection. Cells were microinjected using a biosensor concentration of 40M in the microinjection needle, and were allowed to recover for 30-60min prior to imaging experiments. MEFs were stimulated using 30ng/mL PDGF (Sigma). For inhibiting SFKs PTK1 cells were treated with 10M PP2 (Sigma).
Imaging was performed on an Olympus IX81 motorized inverted microscope equipped with ZDC focus drift compensator, a cooled digital 12-bit CCD camera (CoolSnap, Roper Scientific), a 100W Mercury arc lamp, and MetaMorph imaging software. Images were acquired using a 40X UPlanFLN 1.3 NA oil immersion objective (fibroblast cell experiments) or a 60X 1.2 NA UApo N Silicon oil immersion objective (PTK1 epithelial cells). A Multi-pass dichroic mirror (89006bs, Chroma) was used with the following band pass filters: m-Cerulean (ET 436/20, ET 480/40) and Mero-53 (HQ580/30, HQ 630/40). Images were acquired and processed as previously described 7, 8 .
Automated linescanning and analysis of Src activity
The response of the biosensor was analyzed using automated line scanning software. Line scans of length 100 pixels (~20 m) were calculated at every pixel around the edge of the cell and oriented into the cell in a direction normal to the edge. The normal vector was calculated by making a binary image of the cell (pixels inside the cell equal one) and background, then applying a Gaussian filter to the image. This results in a gradient from zero to one across the cell edge. A contour line (of equal intensities) around the cell edge was taken a smooth approximation to the pixilated edge. From this a smooth normal vector was calculated. The normal vector at a pixel on the edge of the cell was taken to be the nearest normal vector on the contour. Intensities along the scanning line were bi-linearly interpolated from the four neighboring pixels.
Velocity of the cell boundary in between subsequent images was calculated by a mechanical model similar to that described previously 9 . However, we altered this model to include 1/r 2 repulsion terms between marker points on the boundary in order to avoid topological violations.
Each linescan originates at a pixel at the cell edge, and for each pixel we calculated a velocity from the mechanical model. Linescans were then grouped by velocity into bins of width 0.0022 m s -1
. As a result of this analysis we stored a matrix indexed by velocity in one dimension and linescan depth in the other. We also stored the number of pixels in each velocity bin.
Nine Ptk1 cells were analyzed in this fashion. The results were averaged by a weighted mean (by the number of pixels in each bin) of the nine velocity-linescan matrices. Five of the nine cells were treated with PP2 at a given time-point. Unless otherwise noted, the data from before PP2 treatment was used. The post-PP2 data was compared with pre-PP2 treatment in the same cells, so n=5 in this analysis. For the standard error see legend to main text Fig. 5a . The difference between the intensity ratios before and after PP2 addition at 1m was significance tested using a t-test with equal variance and unequal sample sizes. Before PP2 treatment n=119,721 and for after n=135,511, and the standard deviation in both cases was ~0.12.
Modeling of dye on 1F11/SH3 interface
Structure models were generated with the AnchoredDesign package within the Rosetta3 series of software 10 . This package was designed to model docked structures mediated by flexible surface loops, especially where there was evidence for a particular binding mode. In this case, the polyproline motif in 1F11 was aligned to a sequence-matched polyproline motif in PDB structure 1QWF, which contains a peptide bound to a cSrc SH3 domain 11, 12 . Starting from this structure, and holding the polyproline region constant, the surface loops of the monobody (including the regions mutated by Karatan et al Unbound models were produced in the same fashion, except that the cSrc-SH3 domain was not present as a docking partner and the polyproline motif was not held constant.
Approximately 6000-7000 structures were produced for each bound model (positions 24, 53, and 55), and approximately twice as many for the unbound models. This represents approximately 1024 processor-days on a 2.3 GHz processor per group of models.
